NCT02175199

Brief Summary

The purpose of this study is to evaluate the comfort of color contact lenses in a population of clear contact lens wearers who have an interest in wearing color contact lenses.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
151

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

June 24, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 26, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

October 14, 2015

Completed
Last Updated

October 14, 2015

Status Verified

September 1, 2015

Enrollment Period

3 months

First QC Date

June 24, 2014

Results QC Date

September 14, 2015

Last Update Submit

September 14, 2015

Conditions

Keywords

Contact lensVision careDaily wearColor contact lens

Outcome Measures

Primary Outcomes (1)

  • Lens Comfort Likert Response at Day 30

    Subject indicated agreement with the following statement, "These lenses provided the same excellent comfort at the end of the month as they did at the beginning of the month" using a 4-point Likert scale, where 1=Strongly disagree, 2=Disagree; 3=Agree; 4=Strongly agree. The Top 2 responses (agree, strongly agree) were calculated and reported as a percentage of all responses. Both eyes were rated together. This outcome measure was prespecified for the AIR OPTIX COLORS arm only.

    Day 30

Secondary Outcomes (2)

  • Lens Comfort Likert Response at Day 14

    Day 14

  • Lens Comfort 1-10 Scale Response

    Day 30

Study Arms (2)

AIR OPTIX COLORS

EXPERIMENTAL

Lotrafilcon B contact lenses with color printing worn bilaterally in a daily wear modality 5 days/week, 8 hours/day for 30 days.

Device: Lotrafilcon B contact lenses with color printing

FreshLook COLORBLENDS

ACTIVE COMPARATOR

Phemfilcon A contact lenses with color printing worn bilaterally in a daily wear modality 5 days/week, 8 hours/day for 30 days with a 2-week replacement.

Device: Phemfilcon A contact lenses with color printing

Interventions

Also known as: AIR OPTIX® COLORS
AIR OPTIX COLORS
Also known as: FreshLook® COLORBLENDS®
FreshLook COLORBLENDS

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Willing to sign an Informed Consent Document or Assent, if applicable.
  • Vision correctable to 20/30 Snellen (feet) or better in each eye at distance with pre-study contact lenses.
  • Manifest cylinder (at screening) less than or equal to 0.75 diopters (D) in each eye.
  • Successful wear of clear/handling tint, single-vision spherical, bi-weekly/ monthly replacement soft contact lenses in both eyes during the past 2 months for a minimum of 5 days per week and 8 hours per day.
  • Requires spherical contact lenses within the available range of powers (i.e.,-1.50D to -5.00D in 0.25D steps).
  • Interested in wearing contact lenses that change the appearance of the color of the eyes.

You may not qualify if:

  • Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear (within 7 days of enrollment, or current).
  • History of herpetic keratitis.
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated including any use of topical ocular medications that would require instillation during contact lens wear, except for rewetting drops.
  • Corneal vascularization greater than 1 millimeter (mm) of penetration.
  • Habitual lenses worn in an extended wear modality (routinely sleeping in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment.
  • Previous corneal or refractive surgery or irregular cornea.
  • Monovision and monocular (only 1 eye with functional vision) or fit with only 1 lens.
  • Anisometropia ≥1.50D (study contact lens prescription).
  • History of intolerance or hypersensitivity to any component of the test articles.
  • Eye injury or ocular or intra-ocular surgery within the last 6 months (excluding placement of punctal plugs).
  • Participation in any clinical study within 30 days of Visit 1.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Global Brand Lead, GCRA, Vision Care
Organization
Alcon Research, Ltd.

Study Officials

  • Global Brand Lead, GCRA, Vision Care

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2014

First Posted

June 26, 2014

Study Start

June 1, 2014

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

October 14, 2015

Results First Posted

October 14, 2015

Record last verified: 2015-09